CXCL12 and neoplasm: IGS can be then envisaged as a survey process that exposes tumor tissues to immunosurveillance: in a small percentage of cases, this event leads to tumor rejection and antitumor immunity; in a large percentage, instead, the tumor-promoting activity of the CXCL12/CXCR4 axis prevails.